Circumstances leading to the formulation and implementation of a new TB control program in Israel: a case study in public health and policy.
We describe how Israel effected new tuberculosis programs and policies beginning in the early 1990s. We explain how the epidemiology of the disease, particular events, and a small number of people influenced the creation of new policy. We believe that this story may be useful to other program managers and policymakers interested in changing course.
Weiler-Ravell
Daniel
D
Division of Respiratory Physiology and Chest Disease, Carmel Medical Center, Haifa, Israel. weiler@actcom.co.il
Leventhal
Alex
A
Berlowitz
Yitzhak
Y
Rishpon
Shmuel
S
Chemtob
Daniel
D
D000995:Antitubercular Agents / Q000627:therapeutic use; D003140:Communicable Disease Control / Q000458:organization & administration*; D006801:Humans; D015994:Incidence; D007557:Israel / Q000453:epidemiology; D009313:National Health Programs / Q000458:organization & administration*; D015995:Prevalence; D011640:Public Policy; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
D000995:Antitubercular Agents